Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 12/8/2009
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 0||UN / IM|
Administered by: Unknown Purchased by: Unknown
Symptoms: Embolism venous, Visual impairment
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: Unknown
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0911USA02488
Write-up:Information has been received from a physician concerning a $g40 year old female, who in August 2009, was vaccinated IM with 0.5 ml first dose of GARDASIL (dose and lot number not reported). This report was part of a study. Two months after the vaccination (approximately in October 2009), the patient had a visual problem that after consulting with her ophthalmologist, the patient was diagnosed with eye thromboemboli. The patient went to the physician for medical care and the visual problem was only recovered by 10%. In October 2009, the patient went again to the physician for medical care but seeing a different doctor and the patient was diagnosed with venous thromboemboli. At the time of the report the outcome of the patient was not recovered. At this time, relationship of eye thromboemboli vena to study therapy is unknown. The physician felt that the Thrombo emboli vena was considered to be disabling. Additional information has been expected.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166